This White Paper provides a foundational understanding of insights management, including the definition and value of insights, processes and technologies for insights management, and key challenges in implementation.
This Webinar series explores the fundamental concept of big data in Medical Affairs, from which sources can we retrieve this, what are the broader considerations when utilizing data in health and what impact this can have on our organizations, physicians, and patients, now and in the future. These presentations will feature real world cases that are relevant to regional and country Medical Affairs leaders, in order to highlight long-term aspirational and short-term tangible projects.
In this episode, MAPS speaks with Mark Michalski, former radiologist and currently Worldwide Head, Healthcare & Life Sciences, Artificial Intelligence and Machine Learning, Amazon Web Services about how we can catch up with big tech in our ability to mine data for meaning.
Instead of being static representations of an event, insights can become actionable—informing what can be done to improve future events or even larger business decisions.
This paper explores the Medical Affairs-based medical insights function and and identifies basic operational elements required to establish medical insights as a core strategic MA function.
What is Medical Affairs and what does it do in the biopharmaceutical and MedTech industries? Who works in Medical Affairs and what skills do you need to succeed? Find out in this essential guide to understanding, joining and thriving in Medical Affairs.
In this white paper, MedComms, Field Medical and Insights Focus Area Working Groups (FAWGs) demonstrate the value of and elucidate best practices for an insights-driven collaborative approach to creating an iMC S/P.
One of the pandemic’s silver linings may well be gains in participation levels and the volume and quality of insights generated by eliminating the constraints of face-to-face interaction.
This podcast focuses on applications of Real World Evidence including FDA criteria for accepting RWE, types of data, RWE study designs and the Totality of Evidence approach.
In this webinar, our panelists share their experience, challenges, and practical solutions regarding driving insights into action.